eMedicine Specialties > Radiology > Obstetrics/Gynecology

Intrauterine Growth Retardation

Author: Vikram S Dogra, MD, Professor of Diagnostic Radiology, Urology, and Biomedical Engineering, University of Rochester School of Medicine; Director, Division of Ultrasound, Associate Chair of Education and Research, Department of Imaging Sciences, University of Rochester Medical Center
Coauthor(s): Shweta Bhatt, MBBS, MD, Clinical Fellow, Department of Imaging Sciences, University of Rochester Medical Center, Rochester , NY
Contributor Information and Disclosures

Updated: Nov 17, 2009

Introduction

Background

The term intrauterine growth restriction has largely replaced the term intrauterine growth retardation (IUGR). The definition of IUGR is a problematic one because we do not know the inherent growth potential of the fetus. The most common definition used is fetal weight below the 10th percentile for gestational age.

Transabdominal sonogram of an intrauterine pregna...

Transabdominal sonogram of an intrauterine pregnancy with marked oligohydramnios associated with intrauterine growth retardation. It is difficult to appreciate the fetal anatomy in the presence of oligohydramnios.

Transabdominal sonogram of an intrauterine pregna...

Transabdominal sonogram of an intrauterine pregnancy with marked oligohydramnios associated with intrauterine growth retardation. It is difficult to appreciate the fetal anatomy in the presence of oligohydramnios.


Normal spectral Doppler waveform of umbilical art...

Normal spectral Doppler waveform of umbilical artery and vein in a near-term fetus.

Normal spectral Doppler waveform of umbilical art...

Normal spectral Doppler waveform of umbilical artery and vein in a near-term fetus.


Spectral Doppler waveform of umbilical artery in ...

Spectral Doppler waveform of umbilical artery in intrauterine growth retardation (IUGR) demonstrates loss of diastolic flow. Pulsatility of the umbilical vein can also be seen. Both of these findings suggest severe IUGR, and when seen, a perinatologist should be immediately informed.

Spectral Doppler waveform of umbilical artery in ...

Spectral Doppler waveform of umbilical artery in intrauterine growth retardation (IUGR) demonstrates loss of diastolic flow. Pulsatility of the umbilical vein can also be seen. Both of these findings suggest severe IUGR, and when seen, a perinatologist should be immediately informed.


 

In most cases of fetal growth restriction, the transcerebellar diameter appears to be spared and can be used as an unbiased measure of gestational age. The transcerebellar diameter in millimeters is equal to gestational age in weeks to 22 weeks of gestation. With this definition, IUGR and "small for gestational age" are synonymous terms.

IUGR has a prevalence of 10% for all pregnancies. However, the figure varies in different patient populations, with rates of 3-5% for healthy mothers and 25% or higher for some high-risk groups, such as hypertensive mothers. Growth-restricted pregnancies are often complicated by a high rate of antepartum and intrapartum fetal distress and the need for cesarean delivery. Infants who are small for their gestational dates are predisposed to low APGAR scores, low cord pH, intraventricular hemorrhage, necrotizing enterocolitis, hypoglycemia, hypocalcemia, and polycythemia.

Recent studies

According to Proctor et al, small placental size and elevated alpha-fetoprotein (AFP) can identify women with low maternal serum pregnancy-associated plasma protein-A (PAPP-A) who are at high risk for IUGR, preterm delivery before 32 weeks' gestation, and stillbirth. The authors noted that screening studies for trisomy 21 have demonstrated that low PAPP-A at 11-13 weeks' gestation is associated with stillbirth, IUGR, and preeclampsia in chromosomally normal fetuses but that the strength of these associations is too weak to justify screening for these placental insufficiency syndromes. They therefore evaluated placental size and uterine artery Doppler imaging as second-stage screening tests for women (90 normal singleton pregnancies) with low PAPP-A and found that the risks of IUGR, preterm delivery before 32 weeks' gestation, and stillbirth were significantly associated with small placental size and elevated AFP but not with abnormal uterine artery Doppler indices.1

Melchiorre et al found that there is a significant relationship between first-trimester uterine artery Doppler resistance indices (RI) and the subsequent delivery of neonates who are small for gestational age (SGA) or have intrauterine growth restriction (IUGR). They found, however, that the sensitivity of first-trimester uterine artery Doppler is greater for SGA with preeclampsia than it is for IUGR alone and noted that this difference could be the result of different underlying placental abnormalities that are detected variably on first-trimester uterine artery Doppler evaluation. In this study, the first-trimester uterine artery mean RI and prevalence of bilateral notching were significantly higher in women who subsequently delivered neonates with SGA than in women with normal pregnancies. The areas under the receiver-operating characteristics curves for the prediction of SGA without preeclampsia, IUGR, preterm IUGR, and SGA with preeclampsia were 0.602, 0.687, 0.776, and 0.708, respectively.2

Scifres et al evaluated whether maternal demographic and ultrasound parameters predict perinatal mortality (in utero death or neonatal death within the first 28 days of life) in preterm IUGR (delivery gestational age < 35 weeks and birth weight < 10th percentile for gestation). Two hundred thirty singleton pregnancies with preterm IUGR meeting the study inclusion criteria were identified. Oligohydramnios (amniotic fluid index <5) and abnormal umbilical artery Dopplers (absent or reverse end-diastolic flow) were found to have modest predictive value for perinatal mortality.3

In a prospective study (2005-2007) by Bastek et al of 93 women with severe preeclampsia and ultrasound 3 weeks or less before delivery, current ultrasound practice was noted to have moderately good positive and negative predictive values and a high specificity for the diagnosis of IUGR in women with severe preeclampsia. However, according to the authors, the poor sensitivity (56.7%) and low positive likelihood ratio (8.9) indicate that additional modalities are needed to improve the usefulness of ultrasound in detecting IUGR in severe preeclampsia.4

For excellent patient education resources, visit eMedicine's Pregnancy and Reproduction Center.

Pathophysiology

Etiology

The causes of intrauterine growth retardation (intrauterine growth restriction; IUGR) can be either fetal or maternal.5

Fetal causes of IUGR include aneuploidy, trisomy 13, trisomy 18, triploidy, intrauterine infection, cytomegaloviral infection, and toxoplasmosis.

Maternal causes of IUGR include use of drugs (including recreational drugs such as marijuana), alcohol consumption, placental insufficiency, diabetes, late conception (possible cause), and a history of having a baby small for his or her age.

Asymmetrical vs symmetrical IUGR

In most cases of IUGR, especially those due to primary placental insufficiency, the fetal abdomen is small, but the head and extremities are normal or near normal. This finding is known as the head-sparing effect. In cases of severe, early-onset IUGR (those due to chromosomal anomalies), the fetus tends to be more symmetrically small. This condition leads to the existence of 2 distinct subgroups; however, these subgroups significantly overlap.

Fetal villus circulation

The placenta is the lifeline to the fetus, and when challenged, it has a remarkable ability to adapt. Developmental problems can occur from the maternal side, the fetal side, or both. To understand these problems, knowledge of the development and the physiology of the villus circulation is needed.

In the first trimester, the endometrium is invaded by the mesenchymal villi, which are made up of trophoblast, stroma, and a core of vessels. Early in pregnancy, the mesenchymal villi transform into immature intermediate stem villi, which then differentiate into stem villi. The primary-, secondary-, and tertiary-stem villi form the scaffolding from which subsequent villi develop. The histologic structure of the terminal villi optimizes maternal-fetal transfer of nutrients and oxygen. Vascularization of the villi occurs in the first and second trimesters by the process of branching angiogenesis.

Three basic theories regarding the mechanics of the placental circulation are described. As reported in one color Doppler investigation, the theory that best suits these findings is the Ramsey theory. In this mechanism, blood enters the intervillous spaces via the spiral arteries. While moving within the intervillous space, the maternal blood bathes the individual units, which are composed of a fetal arterial, venous, and capillary network. The maternal blood then leaves the intervillous space by the draining basal veins.

The transfer of oxygen and nutrients occurs at the interface between the terminal and intermediate mature villi and the intervillous space. Oxygen and nutrients enter the fetal villous venous circulation and are transferred to the fetus via the umbilical cord.

Kingdom et al demonstrated that maldevelopment of the villus tree in pregnancies complicated by fetal growth restriction is associated with abnormal uterine artery waveforms, which are Doppler findings indicating abnormal uteroplacental blood flow.6 In pregnancies also complicated by absent end-diastolic umbilical flow, the placental villi are elongated, and the capillary loops are uncoiled and sparse. These findings are correlated with an increase in fetal-placental vascular impedance and impair gas and nutrient exchange. An enhanced branching angiogenesis represents an adaptive response to impaired uteroplacental blood flow.

Frequency

United States

By definition, the prevalence of intrauterine growth retardation (intrauterine growth restriction; IUGR) is 10%; fetuses with an estimated weight of less than 10% for gestational age are defined as being growth restricted.

Mortality/Morbidity

The perinatal mortality for infants with intrauterine growth retardation (intrauterine growth restriction; IUGR) is 6-10 times greater than that of a normal-growth population. IUGR is a major cause of intrapartum fetal distress, intrapartum asphyxia, hypoglycemia, hypocalcemia, meconium aspiration, and intrauterine demise.

Sex

Intrauterine growth retardation (intrauterine growth restriction; IUGR) affects only pregnant women.

Age

The incidence of intrauterine growth retardation (intrauterine growth restriction; IUGR) increases with increasing maternal age.

Presentation

Intrauterine growth retardation (intrauterine growth restriction; IUGR) is usually related to preeclampsia.

Preferred Examination

The preferred method for evaluating intrauterine growth retardation (intrauterine growth restriction; IUGR) is ultrasonographic examination.7

More on Intrauterine Growth Retardation

Overview: Intrauterine Growth Retardation
Imaging: Intrauterine Growth Retardation
Follow-up: Intrauterine Growth Retardation
Multimedia: Intrauterine Growth Retardation
References
Further Reading

References

  1. Proctor LK, Toal M, Keating S, Chitayat D, Okun N, Windrim RC, et al. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. Sep 2009;34(3):274-82. [Medline].

  2. Melchiorre K, Leslie K, Prefumo F, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction. Ultrasound Obstet Gynecol. May 2009;33(5):524-9. [Medline].

  3. Scifres CM, Stamilio D, Macones GA, Odibo AO. Predicting perinatal mortality in preterm intrauterine growth restriction. Am J Perinatol. Nov 2009;26(10):723-8. [Medline].

  4. Bastek JA, Pare E, Wang E, Elovitz MA, Srinivas SK. Limitations of ultrasound in diagnosing intrauterine growth restriction in severe preeclampsia. J Matern Fetal Neonatal Med. Jun 29 2009;1-6. [Medline].

  5. Randhawa RS. The insulin-like growth factor system and fetal growth restrictionn. Pediatr Endocrinol Rev. Dec 2008;6(2):235-40. [Medline].

  6. Kingdom JC, Burrell SJ, Kaufmann P. Pathology and clinical implications of abnormal umbilical artery Doppler waveforms. Ultrasound Obstet Gynecol. Apr 1997;9(4):271-86. [Medline].

  7. Grivell RM, Wong L, Bhatia V. Regimens of fetal surveillance for impaired fetal growth. Cochrane Database Syst Rev. Jan 21 2009;CD007113. [Medline].

  8. Kurjak A, Azumendi G, Andonotopo W. Three- and four-dimensional ultrasonography for the structural and functional evaluation of the fetal face. Am J Obstet Gynecol. Sep 29 2006.

  9. Jasovic-Siveska EI, Jasovic VI. Real-time ultrasound in the detection of intrauterine growth retardation in preeclampsia. Bratisl Lek Listy. 2008;109(9):405-11. [Medline].

  10. Palma-Dias RS, Fonseca MM, Brietzke E, Fritsch A, Schlatter D, Maurmann CB, et al. Screening for placental insufficiency by transvaginal uterine artery Doppler at 22-24 weeks of gestation. Fetal Diagn Ther. 2008;24(4):462-9. [Medline].

  11. Phupong V, Dejthevaporn T. Predicting risks of preeclampsia and small for gestational age infant by uterine artery Doppler. Hypertens Pregnancy. 2008;27(4):387-95. [Medline].

  12. Hadlock FP, Harrist RB, Carpenter RJ. Sonographic estimation of fetal weight. The value of femur length in addition to head and abdomen measurements. Radiology. Feb 1984;150(2):535-40. [Medline].

  13. Benson CB, Doubilet PM, Saltzman DH. Intrauterine growth retardation: predictive value of US criteria for antenatal diagnosis. Radiology. Aug 1986;160(2):415-7. [Medline].

  14. Bewley S, Cooper D, Campbell S. Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol. Sep 1991;98(9):871-9. [Medline].

  15. Bower S, Vyas S, Campbell S, Nicolaides KH. Color Doppler imaging of the uterine artery in pregnancy: normal ranges of impedance to blood flow, mean velocity and volume of flow. Ultrasound Obstet Gynecol. Jul 1 1992;2(4):261-5. [Medline].

  16. Doubilet PM, Benson CB. Sonographic evaluation of intrauterine growth retardation. AJR Am J Roentgenol. Mar 1995;164(3):709-17. [Medline].

  17. Lazebnik N, Lazebnik RS. Doppler Evaluation in intrauterine growth-restricted fetuses. In: Dogra VS, Rubens DJ, eds. Philadelphia, Pa: Hanley & Belfus; 2003:67-74.

  18. Manning FA. The use of sonography in the evaluation of the high-risk pregnancy. Radiol Clin North Am. Jan 1990;28(1):205-16. [Medline].

  19. Paspulati RM, Bhatt S, Nour S. Sonographic evaluation of first-trimester bleeding. Radiol Clin North Am. Mar 2004;42(2):297-314. [Medline].

  20. Shepard MJ, Richards VA, Berkowitz FL. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol. 1982;142:47.

Keywords

intrauterine growth retardation, IUGR, intrauterine growth restriction, fetal growth, small for gestational age, asymmetric IUGR, symmetric IUGR, asymmetrical IUGR, symmetrical IUGR, growth-restricted fetus, transcerebellar diameter, head-sparing effect, abdominal circumference, head circumference, biparietal diameter, oligohydramnios

Contributor Information and Disclosures

Author

Vikram S Dogra, MD, Professor of Diagnostic Radiology, Urology, and Biomedical Engineering, University of Rochester School of Medicine; Director, Division of Ultrasound, Associate Chair of Education and Research, Department of Imaging Sciences, University of Rochester Medical Center
Vikram S Dogra, MD is a member of the following medical societies: American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Association of Program Directors in Radiology, Radiological Society of North America, Society of Radiologists in Ultrasound, and Society of Uroradiology
Disclosure: Nothing to disclose.

Coauthor(s)

Shweta Bhatt, MBBS, MD, Clinical Fellow, Department of Imaging Sciences, University of Rochester Medical Center, Rochester , NY
Shweta Bhatt, MBBS, MD is a member of the following medical societies: Radiological Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Christopher L Sistrom, MD, Associate Chair for Research, Assistant Professor, Department of Radiology, University of Florida School of Medicine
Christopher L Sistrom, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Association of University Radiologists, Phi Beta Kappa, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Karen L Reuter, MD, FACR, Professor, Department of Radiology, Lahey Clinic Medical Center
Karen L Reuter, MD, FACR is a member of the following medical societies: American Association for Women Radiologists, American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.